- Home
- AZN vs TMO Comparison
AZN vs TMO Comparison
Compare AZN & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZN
- TMO
- Stock Information
- Founded
- AZN 1992
- TMO 1956
- Country
- AZN United Kingdom
- TMO United States
- Employees
- AZN N/A
- TMO N/A
- Industry
- AZN Biotechnology: Pharmaceutical Preparations
- TMO Industrial Machinery/Components
- Sector
- AZN Health Care
- TMO Industrials
- Exchange
- AZN Nasdaq
- TMO Nasdaq
- Market Cap
- AZN 233.8B
- TMO 203.5B
- IPO Year
- AZN 1993
- TMO N/A
- Fundamental
- Price
- AZN $76.36
- TMO $512.28
- Analyst Decision
- AZN Strong Buy
- TMO Strong Buy
- Analyst Count
- AZN 7
- TMO 20
- Target Price
- AZN $89.75
- TMO $652.65
- AVG Volume (30 Days)
- AZN 6.2M
- TMO 1.9M
- Earning Date
- AZN 04-24-2025
- TMO 04-23-2025
- Dividend Yield
- AZN 2.04%
- TMO 0.33%
- EPS Growth
- AZN 18.11
- TMO 6.99
- EPS
- AZN 4.50
- TMO 16.53
- Revenue
- AZN $54,073,000,000.00
- TMO $42,879,000,000.00
- Revenue This Year
- AZN $8.64
- TMO $3.35
- Revenue Next Year
- AZN $6.11
- TMO $6.60
- P/E Ratio
- AZN $16.77
- TMO $31.00
- Revenue Growth
- AZN 18.03
- TMO 0.05
- 52 Week Low
- AZN $62.75
- TMO $493.30
- 52 Week High
- AZN $87.68
- TMO $627.88
- Technical
- Relative Strength Index (RSI)
- AZN 60.78
- TMO 36.67
- Support Level
- AZN $74.18
- TMO $509.41
- Resistance Level
- AZN $78.25
- TMO $536.21
- Average True Range (ATR)
- AZN 1.00
- TMO 12.08
- MACD
- AZN -0.27
- TMO -0.85
- Stochastic Oscillator
- AZN 62.56
- TMO 9.51
About AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (22%); and lab products and services, which includes CRO services (54%).